Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, New Jersey, USA.
Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
J Dermatol. 2023 Sep;50(9):1099-1107. doi: 10.1111/1346-8138.16895. Epub 2023 Jul 25.
Medication non-adherence is currently estimated to have caused at least 100 000 preventable deaths and over $100 billion in preventable medical costs. Adherence is particularly poor in dermatological conditions, with more than 50% of patients discontinuing topical treatments within the first year. Pharmacists are among the most accessible health-care professionals with the potential to greatly impact medication non-adherence through patient education, medication therapy management, and improved access to care. This review aimed to determine how pharmacists have improved medication adherence in dermatology and discuss strategies for further involvement. An extensive medical literature search using the PubMed database was conducted to evaluate clinical studies, published in the last 20 years, that have evaluated the pharmacist's role and impact on adherence of to dermatological products. PubMed search terms include: "pharmacists' role in dermatologic medication adherence", "pharmacist-led interventions in dermatology", "pharmacist medication adherence dermatology" and "pharmacist intervention dermatology". A total of 18 relevant studies were identified. Pharmacists improved dermatological medication adherence by increasing access to medications, providing medication counseling programs, and performing treatment monitoring services. However, corticophobia may contribute to pharmacists' hesitancy in making corticosteroid over-the-counter recommendations. Pharmacists are accessible health-care providers with the potential to improve dermatological medication adherence. Future advanced training in dermatology medications may refine pharmacists' knowledge of dermatological products.
药物不依从目前估计至少导致了 10 万例可预防的死亡和超过 1000 亿美元的可预防医疗费用。在皮肤科疾病中,依从性尤其差,超过 50%的患者在第一年就停止了局部治疗。药剂师是最容易接触到的医疗保健专业人员之一,他们有可能通过患者教育、药物治疗管理和改善获得护理的机会,极大地影响药物不依从性。这篇综述旨在确定药剂师如何改善皮肤科的药物依从性,并讨论进一步参与的策略。使用 PubMed 数据库进行了广泛的医学文献检索,以评估过去 20 年发表的评估药剂师在皮肤科产品依从性方面的作用和影响的临床研究。PubMed 搜索词包括:“药剂师在皮肤科药物依从性中的作用”、“药剂师主导的皮肤科干预措施”、“药剂师在皮肤科药物依从性中的作用”和“药剂师干预皮肤科”。共确定了 18 项相关研究。药剂师通过增加药物的获取途径、提供药物咨询计划和进行治疗监测服务,提高了皮肤科药物的依从性。然而,皮质恐惧症可能导致药剂师在建议皮质类固醇非处方药物时犹豫不决。药剂师是可接触的医疗保健提供者,有潜力提高皮肤科药物的依从性。未来在皮肤科药物方面的高级培训可能会提高药剂师对皮肤科产品的了解。